Vivodyne

cofounders Andrei Georgescu (left), now Vivodyne’s CEO, and UPenn Professor Dan Huh (right), now Vivodyne’s CSO
Vivodyne launches with $38M to create lab-grown human organs
By Jessica Hagen | 04:18 pm | November 22, 2023
The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.